Status:
RECRUITING
The Relationship Between Scar Formation and ESD Depth in Therapy for Gastric Carcinoma
Lead Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University
Conditions:
Early Gastric Cancer
Endoscopic Submucosal Dissection
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
This study is a single-center, prospective, group-controlled clinical trial, aiming to clarify the relationship between the depth of dissection and scar formation in the treatment of early gastric can...
Detailed Description
This project intends to compare the scar size of ESD for early gastric cancer with different peeling depths, explore the relationship between ESD peeling depth, scar formation and gastric function, an...
Eligibility Criteria
Inclusion
- Patients older than 18 years old and younger than 75 years old.
- Early gastric cancer (T1a stage) diagnosed by gastroscopy or ultrasonography, differentiated and no ulcer; or early gastric cancer (T1a stage), differentiated with ulcer, lesion diameter \<3cm; or early gastric cancer (T1a stage), undifferentiated and No ulcer, lesion diameter \<2cm.
- Pathological diagnosis of gastric cancer.
- No further treatment is required.
- Patients diagnosed for the first time without other serious gastrointestinal diseases.
Exclusion
- Those who did not comply with the test requirements, obviously violated this protocol, or switched to other protocols in the middle of treatment.
- Advanced gastric cancer; or undifferentiated gastric cancer lesions \> 2 cm in diameter; or differentiated gastric cancer with ulcer lesions \> 3 cm in diameter.
- Coagulation disorders.
- Serious heart, liver, kidney and other diseases, can not tolerate ESD treatment.
- Patients with gastric cancer complications such as gastrointestinal bleeding and perforation that need emergency treatment.
- Patients with distant metastasis.
- Patients with other tumors, patients with a history of malignant tumors (except early carcinoma in situ.
- The patient himself requests to withdraw from the trial.
- The researcher believes that the patient is not suitable to participate in this study.
Key Trial Info
Start Date :
January 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT05323929
Start Date
January 1 2022
End Date
December 31 2027
Last Update
April 14 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Second affiliated hospital, school of medicine, Zhejiang University
Hangzhou, Zhejiang, China, 310000